RANBP17 and neoplasm: As depicted in Supplementary Fig. S7A, immune cells exhibit only low RanBP17 expression levels and therefore do not appear to account for the elevated RanBP17 levels in tumor tissues with high TIL levels as found in HPV+ HNSCC.